Prostate cancer decisions — 2021

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with the requirements under Diagnostic Code 7528.

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with the requirements under Diagnostic Code 7528.

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with all requirements under Diagnostic Code 7528.

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with the requirements under Diagnostic Code 7528.

The Board found that the discontinuation of the 100 percent rating for prostate cancer effective October 1, 2021 was proper based on the cessation of treatment and VA's compliance with the requirements under Diagnostic Code 7528.

The Veteran's anxiety disorder is rated at 50 percent, effective as of the date of this decision.,The Veteran is granted TDIU based on his service-connected disabilities.

The Veteran's prostate cancer is presumed to be related to his in-service exposure to an herbicide agent while stationed at Korat RTAFB, and the Board has granted service connection for this condition.

The Veteran's service-connected disabilities do not prevent him from obtaining or maintaining a substantially gainful occupation.

The Board has determined that new and relevant evidence has been submitted for the claims of service connection for Type II Diabetes Mellitus, Residuals of Prostate Cancer, Skin Condition, and Peripheral Neuropathy. The Veteran's exposure to herbicide agents in Thailand is now conceded, but further examination is needed to determine the nature and etiology of his skin condition and peripheral neuropathy.

The Board has determined that new and relevant evidence has been submitted for the claims of service connection for Type II Diabetes Mellitus, Residuals of Prostate Cancer, Skin Condition, and Peripheral Neuropathy. The Veteran's exposure to herbicide agents in Thailand is now conceded. The claims are remanded for further examination and opinion regarding the nature and etiology of these conditions.

The Veteran's PTSD is rated at 50 percent, which is the maximum rating available under DC 9411.,The Veteran's prostate cancer is currently rated at 40 percent for voiding dysfunction. The Board has granted a TDIU based on his service-connected disabilities and overall unemployability due to PTSD.,A total disability based on individual unemployability (TDIU) is granted.

The Board has determined that new and relevant evidence has been submitted for the claims of service connection for Type II Diabetes Mellitus, Residuals of Prostate Cancer, Skin Condition, and Peripheral Neuropathy. The Veteran's exposure to herbicide agents in Thailand is now conceded. The claims are remanded for further examination and opinion regarding the nature and etiology of these conditions.

The Veteran's prostate cancer is granted as service connected due to exposure to herbicide agents during his active duty in Thailand. The effective date of the grant will be determined by the AOJ.

The Veteran's claim for an earlier effective date for residuals of bladder cancer is denied as the earliest evidence of a claim was March 14, 2017.,The Veteran's claim for a rating in excess of 20 percent from March 14, 2017 to October 2, 2018 for residuals of bladder cancer with prostate cancer is denied as the symptoms do not warrant such a rating.

The Veteran's claim for compensation under 38 U.S.C. § 1151 for prostate cancer is granted with an effective date of August 15, 2010.

The Board has remanded the case due to insufficient evidence regarding whether the Veteran served at Takhli or U-Tapao RTAFBs while on temporary duty orders, which is necessary for determining if he was exposed to herbicide agents during his service.

The Board has granted service connection for ischemic heart disease and residuals of prostate cancer as due to exposure to herbicide agents while serving in Thailand.

The Board has remanded the case due to new evidence submitted by a third party, and the Veteran requested that his appeal be reviewed by the AOJ.

The Board dismissed all appeals due to the Veteran's death, including those for PTSD, prostate cancer, anemia, and ischemic heart disease.

The Veteran's service-connected disabilities, including prostate cancer and right shoulder and knee conditions, do not preclude him from securing or maintaining substantially gainful employment.